Characterizing red blood cell age exposure in massive transfusion therapy: the scalar age of blood index (SBI)
Stacia M DeSantis, Derek W Brown, Allison R Jones, Jose-Miguel Yamal, Jean-Francois Pittet, Rakesh P Patel, Charles E Wade, John B Holcomb, Henry Wang, PROPPR Study Group, Stacia M DeSantis, Derek W Brown, Allison R Jones, Jose-Miguel Yamal, Jean-Francois Pittet, Rakesh P Patel, Charles E Wade, John B Holcomb, Henry Wang, PROPPR Study Group
Abstract
Background: The mortality of trauma patients requiring massive transfusion to treat hemorrhagic shock approaches 17% at 24 hours and 26% at 30 days. The use of stored RBCs is limited to less than 42 days, so older RBCs are delivered first to rapidly bleeding trauma patients. Patients who receive a greater quantity of older RBCs may have a higher risk for mortality.
Methods and materials: Characterizing blood age exposure requires accounting for the age of each RBC unit and the quantity of transfused units. To address this challenge, a novel Scalar Age of Blood Index (SBI) that represents the relative distribution of RBCs received is introduced and applied to a secondary analysis of the Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) randomized controlled trial (NCT01545232, https://ichgcp.net/clinical-trials-registry/NCT01545232). The effect of the SBI is assessed on the primary PROPPR outcome, 24-hour and 30-day mortality.
Results: The distributions of blood storage ages successfully maps to a parameter (SBI) that fully defines the blood age curve for each patient. SBI was a significant predictor of 24-hour and 30-day mortality in an adjusted model that had strong predictive ability (odds ratio, 1.15 [1.01-1.29], p = 0.029, C-statistic, 0.81; odds ratio, 1.14 [1.02-1.28], p = 0.019, C-statistic, 0.88, respectively).
Conclusion: SBI is a simple scalar metric of blood age that accounts for the relative distribution of RBCs among age categories. Transfusion of older RBCs is associated with 24-hour and 30-day mortality, after adjustment for total units and clinical covariates.
Conflict of interest statement
Conflicts of Interest
The authors, SD, DB, AJ, JMY, JFP, RP, CW, and JH, declare that they have no conflicts of interest relevant to the manuscript submitted to TRANSFUSION.
HW provides research consultation for Shire, Inc.
© 2019 AABB.
Figures
Source: PubMed